Rentschler Biopharma

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) that focuses on customer projects. The company provides process development and manufacturing for biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's long-term experience and excellent performance as a customer solutions partner demonstrate its high quality. A high-level quality management system, a well-established operational excellence philosophy, and advanced technology ensure the quality and productivity of products at every stage of development and manufacturing. To offer first-class formulation development in the biopharmaceutical value chain, the company has formed a strategic alliance with Leukocare AG. Rentschler Biopharma is a family-owned business with approximately 1,000 employees, headquartered in Laupheim, Germany, with a second location in Milford, Massachusetts, USA. In Stevenage, UK, Rentschler Biopharma established Rentschler ATMP Ltd., a company dedicated to cell and gene therapy.